M JAMES BARRETT Insider Trading $SUPN SUPERNUS PHARMACEUTICALS, INC.
Get free email notifications about insider trading for M JAMES BARRETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of M JAMES BARRETT. M JAMES BARRETT is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and Director in PHARMION CORP ($PHRM) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Liquidia Technologies Inc ($LQDA) and Director in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Epizyme, Inc. ($EPZM) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Zosano Pharma Corp ($ZSAN) and Director in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Surface Oncology, Inc. ($SURF).
M JAMES BARRETT in SUPERNUS PHARMACEUTICALS, INC.
Trading Symbol: SUPNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of M JAMES BARRETT: Director
Holdings: 97,355 shares
Current Value: $2,399,801
Latest Transaction: Mar 24 2016
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of M JAMES BARRETT in SUPERNUS PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, ARDM, ARDX, CRCM, CBIO, CERC, CLVS, EPZM, GLYC, HPTX, INHX, INWK, IOMI, ILIU, LIQDA, LOXO, MRSN, MULE, MYOG, PRTK, PHRM, RARX, RYTM, SENS, ROKA, SUPN, SURF, SYBX, TSRO, TCON, VTAE, VG, YMTX, ZSAN, ZHNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 24 2016 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Gift | G | 0.00 | 18,000 | 0 | 97,355 | 115.4 K to 97.4 K (-15.60 %) |
Mar 03 2016 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Option Exercise | A | 12.98 | 15,000 | 194,700 | 15,000 | |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.75 | 70,913 | 1,045,953 | 0 | 70.9 K to 0 (-100.00 %) |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.38 | 71,067 | 1,022,192 | 70,913 | 142 K to 70.9 K (-50.05 %) |
Dec 08 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 14.54 | 70,990 | 1,032,152 | 141,980 | 213 K to 142 K (-33.33 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 212,970 | 0 | 212,970 | 0 to 213 K |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 8,733 | 0 | 24,317 | 15.6 K to 24.3 K (+56.04 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 11,980 | 0 | 33,360 | 21.4 K to 33.4 K (+56.03 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 20,713 | 0 | 57,678 | 37 K to 57.7 K (+56.03 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 41,426 | 0 | 115,355 | 73.9 K to 115.4 K (+56.03 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 1,172,932 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 1,172,932 | 0 | 1,172,932 | 0 to 1.2 M |
Dec 03 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 3,820,625 | 0 | 0 | 3.8 M to 0 (-100.00 %) |
Nov 30 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Option Exercise | M | 9.24 | 7,457 | 68,903 | 0 | |
Nov 30 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Option Exercise | M | 7.90 | 8,722 | 68,904 | 0 | |
Nov 30 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.35 | 16,179 | 264,494 | 73,929 | 90.1 K to 73.9 K (-17.96 %) |
Nov 30 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | M | 9.24 | 7,457 | 68,903 | 90,108 | 82.7 K to 90.1 K (+9.02 %) |
Nov 30 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | M | 7.90 | 8,722 | 68,904 | 82,651 | 73.9 K to 82.7 K (+11.80 %) |
Nov 18 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.50 | 43,000 | 709,543 | 0 | 43 K to 0 (-100.00 %) |
Nov 18 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.71 | 50,000 | 835,460 | 43,000 | 93 K to 43 K (-53.76 %) |
Nov 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.13 | 19,650 | 317,035 | 93,000 | 112.7 K to 93 K (-17.44 %) |
Nov 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.26 | 100,000 | 1,625,610 | 112,650 | 212.7 K to 112.7 K (-47.03 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 212,650 | 0 | 212,650 | 0 to 212.7 K |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 8,728 | 0 | 15,584 | 6.9 K to 15.6 K (+127.30 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 11,974 | 0 | 21,380 | 9.4 K to 21.4 K (+127.30 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 20,703 | 0 | 36,965 | 16.3 K to 37 K (+127.31 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 41,405 | 0 | 73,929 | 32.5 K to 73.9 K (+127.31 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 1,172,932 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 1,172,932 | 0 | 1,172,932 | 0 to 1.2 M |
Nov 12 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 3,820,625 | 0 | 3,820,625 | 7.6 M to 3.8 M (-50.00 %) |
Jun 19 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.02 | 48,796 | 781,800 | 0 | 48.8 K to 0 (-100.00 %) |
Jun 19 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.67 | 63,085 | 1,051,804 | 48,796 | 111.9 K to 48.8 K (-56.39 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | S | 16.85 | 55,105 | 928,668 | 111,881 | 167 K to 111.9 K (-33.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 166,986 | 0 | 166,986 | 0 to 167 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 6,856 | 0 | 6,856 | 0 to 6.9 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 9,406 | 0 | 9,406 | 0 to 9.4 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 16,262 | 0 | 16,262 | 0 to 16.3 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 32,524 | 0 | 32,524 | 0 to 32.5 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 921,000 | 0 | 921,000 | 1.8 M to 921 K (-50.00 %) |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Buy | J | 0.00 | 921,000 | 0 | 921,000 | 0 to 921 K |
Jun 17 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Sell | J | 0.00 | 3,000,000 | 0 | 7,641,250 | 10.6 M to 7.6 M (-28.19 %) |
Mar 05 2015 | SUPN | SUPERNUS PHARMACEU ... | BARRETT M JAMES | Director | Option Exercise | A | 9.13 | 20,000 | 182,600 | 20,000 |
Page: 1